首页> 外文OA文献 >Potential of serum and urinary matrix metalloproteinase-9 levels for the early detection of renal involvement in children with henoch-schonlein purpura
【2h】

Potential of serum and urinary matrix metalloproteinase-9 levels for the early detection of renal involvement in children with henoch-schonlein purpura

机译:血清和尿中基质金属蛋白酶9水平对儿童过敏性紫癜性肾病的早期发现有潜在的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Matrix metalloproteinase-9 (MMP-9) is an enzyme implicated in the pathogenesis of renal diseases. Renal involvement is the principal cause of morbidity and mortality in children with Henoch-Schonlein purpura (HSP). Objectives: The aim of this study was to evaluate whether serum and urinary MMP-9 levels are associated with renal involvement in HSP Patients and Methods: We evaluated 40 children with HSP (patient group) and 27 healthy volunteer children (control group). The patient group was divided into two subgroups based on the presence or absence of nephritis. Nephritis was defined as the existence of hematuria and/or proteinuria. All anthropometric data, physical examination findings, blood pressure, and laboratory parameters were recorded. The serum and urine samples were analyzed to determine the MMP-9 levels three days after the initial phase of the disease. Results: The mean age was 7.65 +/- 3.41 (range 2-16) years in the patient group and 9.52 +/- 3.91 (range 2-16) years in the control group. Henoch-Schonlein purpura nephritis (HSPN) was identified in eight patients. There was no significant difference in the serum MMP-9 levels between the HSPN subgroup and the controls (P > 0.05). However, there were significant differences in the urinary MMP-9 levels between the HSP subgroup and the control group (P < 0.05), with the urinary MMP-9 levels being significantly higher in patients in the HSP subgroup (P = 0.001). Further, the urinary MMP-9 levels were significantly higher in the patients with nephritis than in the patients without nephritis (P = 0.001) and the controls (P = 0.001). The optimal cut-off point (sensitivity; specificity) of the urinary MMP-9 level for the diagnosis of HSPN was 94.7 pg/mL. Conclusions: The levels of MMP-9 in the urine were remarkably high in patients with HSPN. This non-invasive marker may the refore be an important indicator for the early diagnosis of nephritis in children with HSP.
机译:背景:基质金属蛋白酶9(MMP-9)是一种涉及肾脏疾病发病机理的酶。肾脏受累是儿童过敏性紫癜(HSP)患病和死亡的主要原因。目的:本研究的目的是评估HSP患者的血清和尿MMP-9水平是否与肾脏受累有关。方法:我们评估了40例HSP儿童(患者组)和27例健康志愿者儿童(对照组)。根据是否存在肾炎将患者分为两个亚组。肾炎定义为存在血尿和/或蛋白尿。记录所有人体测量数据,体格检查结果,血压和实验室参数。在疾病初始阶段三天后,分析血清和尿液样本以确定MMP-9水平。结果:患者组的平均年龄为7.65 +/- 3.41(范围2-16)岁,对照组为9.52 +/- 3.91(范围2-16)岁。在八名患者中发现了过敏性紫癜性肾炎(HSPN)。 HSPN亚组和对照组之间的血清MMP-9水平无显着差异(P> 0.05)。但是,HSP亚组和对照组之间的尿MMP-9水平存在显着差异(P <0.05),HSP亚组患者的尿MMP-9水平显着较高(P = 0.001)。此外,患有肾炎的患者的尿中MMP-9水平显着高于无肾炎的患者(P = 0.001)和对照组(P = 0.001)。尿MMP-9水平诊断HSPN的最佳截止点(敏感性;特异性)为94.7 pg / mL。结论:HSPN患者尿液中MMP-9水平显着升高。因此,这种非侵入性标志物可能是早期诊断HSP患儿肾炎的重要指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号